CRISPR Therapeutics AG (CRSP)
58.18
+2.19
(+3.91%)
USD |
NASDAQ |
Dec 04, 16:00
58.70
+0.52
(+0.89%)
After-Hours: 20:00
CRISPR Therapeutics Market Cap: 5.545B for Dec. 4, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 116.04B |
| Intellia Therapeutics, Inc. | 1.128B |
| Novartis AG | 254.11B |
| Beam Therapeutics, Inc. | 2.934B |
| BeOne Medicines Ltd. | 36.67B |
Market Cap Related Metrics
| PS Ratio | 132.71 |
| PEG Ratio | -0.1068 |
| Price to Book Value | 2.894 |
| Price | 58.18 |
| Earnings Yield | -9.59% |
| PEGY Ratio | -0.1068 |